
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.87 | 7.53 | 1.66 |
Shares | 94.13 | 94.13 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.54 | 19.98 |
Price to Book | 6.70 | 3.86 |
Price to Sales | 3.02 | 2.55 |
Price to Cash Flow | 16.34 | 13.63 |
Dividend Yield | 1.97 | 1.58 |
5 Years Earnings Growth | 10.23 | 10.90 |
Name | Net % | Category Average |
---|---|---|
Technology | 37.31 | 27.80 |
Healthcare | 24.13 | 12.61 |
Financial Services | 17.45 | 15.00 |
Consumer Cyclical | 13.28 | 10.32 |
Industrials | 7.84 | 9.63 |
Number of long holdings: 13
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 15.24 | 198.78 | -1.92% | |
Microsoft | US5949181045 | 15.20 | 472.62 | +0.36% | |
Ameriprise Financial | US03076C1062 | 8.82 | 515.65 | -0.20% | |
McDonald’s | US5801351017 | 8.33 | 301.72 | +0.43% | |
Merck&Co | US58933Y1055 | 8.22 | 80.32 | -1.27% | |
JPMorgan | US46625H1005 | 7.60 | 268.15 | -0.17% | |
ADP | US0530151036 | 7.38 | 312.37 | -0.68% | |
UnitedHealth | US91324P1021 | 7.32 | 310.56 | +2.23% | |
AbbVie | US00287Y1091 | 7.17 | 191.50 | +1.06% | |
Accenture | IE00B4BNMY34 | 4.68 | 319.22 | -0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Brown Advisory Sustainable Growth I | 6.32B | -9.13 | 11.47 | 14.62 | ||
Brown Advisory Sustainable Growth F | 2.2B | -9.20 | 11.29 | 14.45 | ||
Brown Advisory Somerset Emgerg Mk | 658.4M | 1.99 | 5.61 | 3.07 | ||
Brown Advisory Small-Cap Fdmtl Val | 631.21M | -10.19 | 6.68 | 6.34 | ||
Brown Advisory Flexible Equity Inv | 572.1M | -4.58 | 13.90 | 12.33 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review